Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea
· Delayed Price · Currency is KRW 6,080.00
-20.00 (-0.33%)
At close: Mar 21, 2025, 3:30 PM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 333.43 billion as of April 1, 2025. Its market cap has increased by 291.97% in one year.
Market Cap
333.43B
Enterprise Value
313.46B
Revenue
1.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
6,080.00
Market Cap Chart
Since March 22, 2021, Bridge Biotherapeutics's market cap has increased from 300.48B to 333.43B, an increase of 10.96%. That is a compound annual growth rate of 2.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 337.76B | 108.00% |
| Dec 30, 2024 | 162.38B | 102.52% |
| Dec 28, 2023 | 80.18B | -71.06% |
| Dec 29, 2022 | 277.06B | -17.02% |
| Dec 30, 2021 | 333.88B | 11.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 396.83T |
| SK hynix | 137.33T |
| LG Energy Solution | 83.30T |
| Samsung Biologics | 74.66T |
| Hyundai Motor Company | 44.69T |
| Celltrion | 38.03T |
| Kia Corporation | 37.52T |
| KB Financial Group | 29.19T |